BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2016
View Archived Issues
FDA grants orphan drug designation to ONC-201
Read More
BeiGene's BTK inhibitor granted U.S. orphan status for lymphomas
Read More
Allakos initiates phase I trial of AK-002 in indolent systemic mastocytosis
Read More
Quantum Genomics initiates phase IIa trial of QGC-101 for heart failure
Read More
Results from a phase I trial with autologous MSCNPs in MS patients
Read More
Epiduo approved in Japan
Read More
Merck & Co. patents ERK inhibitors
Read More
Roche and Genentech report retinoid RORgamma ligands
Read More
OncoArendi Therapeutics discloses acidic mammalian chitinase inhibitors
Read More
Estrogen receptor alpha ligands described in Roche and Genentech patent
Read More
PharmNovo patents delta-opioid receptor agonists
Read More
Phase III study of NK-105 does not meet the primary endpoint
Read More
Preliminary results reported for nivolumab in colon, pancreatic and anal cancer
Read More
AstraZeneca initiates first-in-human trial of AZD-4635 in advanced solid tumors
Read More
Topline results reported from Japanese phase III study of AnGes' NF-kappaB decoy oligo
Read More
ZEB1 shows promise as a diagnostic biomarker for GEA
Read More
Targovax begins dosing in phase Ib/II trial of ONCOS-102
Read More
Sanofi Pasteur signs CRADA with WRAIR on Zika vaccine candidate
Read More
Biocryst Pharmaceuticals receives NIAID funding
Read More
Zinbryta approved in European Union for treatment of multiple sclerosis
Read More
IKAROS may be useful as a prognostic biomarker in PADC
Read More
Bristol-Myers Squibb acquires Cormorant Pharmaceuticals and gains full rights to HuMax-IL8
Read More
FDA approves InSys Therapeutic's Syndros
Read More
FDA awards fast track designation to Scenesse for erythropoietic protoporphyria
Read More
Ophtalix releases phase II results for CF-101
Read More